Health
CREB1: A Potential Target for Treating Pancreatic Cancer – Technology Networks
Preclinical research using cell lines, genetic mouse models and human pancreatic tumor tissue samples has identified the transcription factor CREB1 as a potential…
Preclinical experiments using cell lines, genetic mouse models, and human pancreatic tumor tissue identified the transcription factor CREB1 (for cyclic AMP-responsive element binding protein 1) as a potential therapeutic target for the treatment of pancreatic cancer, according to results presented during Week 1 of the virtual AACR Annual Meeting 2021, held April 10-15. This study is being simultaneously published in Cancer Discovery, a journal of the American Association for Cancer Research.
Pancreatic…
-
General9 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General12 hours agoAlbanese beats drum on economy as trade clouds gather
-
Business9 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
Noosa News11 hours agoSurgeon partner of former premier to testify over his patient’s death